Tech Company Inital Public Offerings
Dyne Therapeutics IPO
Dyne Therapeutics was acquired by . Shares were listed on 9/16/2020.
Transaction Overview
Company Name
Announced On
9/16/2020
Transaction Type
IPO
Amount
$233,700,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds together with its existing resources as follows:approximately $225.0 million for continued research and development of our programs, including preclinical studies, IND-enabling studies and clinical trials;approximately $30.0 million for continued development and enhancement of our proprietary FORCE platform; andthe remainder for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
830 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Dyne Therapeutics (Nasdaq: DYN) was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Brumm
Chief Operating Officer
Susanna High
Chief Scientific Officer
Romesh Subramanian
Vice President
John Davis
Vice President
Molly White
Vice President
Daniel Wilson
VP - Administration
Rick Scalzo
VP - Bus. Development
Jonathan McNeill
VP - Bus. Development
Chris Mix
VP - Finance
Gene Kim
VP - Manufacturing
John Najim
VP - R & D
Oxana Beskrovnaya
VP - R & D
Mo Qatanani
VP - Regulatory Affairs
Debra Feldman
Browse more venture capital transactions:
Prev: 9/16/2020: Seeq venture capital transaction
Next: 9/16/2020: Ansa Biotechnologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs